Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Neurogenic Lower Urinary Tract Dysfunction in Women With Multiple Sclerosis.
Journal: Urogynecology (Philadelphia, Pa.)
Published: December 19, 2025
BAFF is a marker of hypogammaglobulinemia, neuroaxonal damage and inflammation in multiple sclerosis patients on ocrelizumab.
Journal: Journal of neuroinflammation
Published: August 04, 2025
USING ARTIFICIAL INTELLIGENCE TO PREDICT TREATMENT OUTCOMES IN PATIENTS WITH NEUROGENIC OVERACTIVE BLADDER AND MULTIPLE SCLEROSIS.
Journal: medRxiv : the preprint server for health sciences
Published: June 30, 2025
Safe immunosuppression-resistant pan-cancer immunotherapeutics by velcro-like density-dependent targeting of tumor-associated carbohydrate antigens.
Journal: Cell
Published: March 26, 2024
N-Glycan Branching Regulates BTLA Opposite to PD-1 to Limit T Cell Hyperactivity Induced by Branching Deficiency.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: August 24, 2023
N-acetylglucosamine inhibits inflammation and neurodegeneration markers in multiple sclerosis: a mechanistic trial.
Journal: Journal of neuroinflammation
Published: August 01, 2023
The Cancer Moonshot Immuno-Oncology Translational Network at 5: accelerating cancer immunotherapies.
The Cancer Moonshot Immuno-Oncology Translational Network at 5: accelerating cancer immunotherapies.
Journal: Journal of the National Cancer Institute
Published: July 17, 2023
The Crossroads of Glycoscience, Infection, and Immunology.
Journal: Frontiers in microbiology
Published: June 25, 2021
N-acetylglucosamine drives myelination by triggering oligodendrocyte precursor cell differentiation.
N-acetylglucosamine drives myelination by triggering oligodendrocyte precursor cell differentiation.
Journal: The Journal of biological chemistry
Published: August 10, 2020
Last Updated: 09/26/2026